help me prepare for this second round interview https://www.linkedin.com/jobs/view/4427968630/
I would love to help you prep and make sure you nail this second round! Because LinkedIn job links sometimes require a sign-in or can change quickly, could you share the job title, key responsibilities, or company details from that link, as well as who you will be interviewing with in this second round?
associate sciencist: We are seeking an experienced scientist with deep, hands-on expertise in histology and antibody validation to join a fast-paced and highly collaborative scientific environment. This role will support multiple ongoing spatial omics projects including biomarker discovery and target validation initiatives requiring someone who is highly adaptable, detail-oriented, and comfortable balancing planned work with urgent, short-term requests. The ideal candidate thrives in a dynamic environment, approaches shifting priorities as an opportunity, and can deliver high-quality work across a broad range of histology and multiplex imaging workflows.
Responsibilities
Contribute to and help shape DAGS multiomics and spatial biology experimental strategies. Support the maintenance, troubleshooting, and optimization of histology instruments and associated laboratory workflows. Maintain, calibrate, and document the use of laboratory equipment in compliance with internal standards. Perform routine and advanced preparation of histological slides from FFPE blocks, including embedding, sectioning, staining, labeling, and quality assessment. Perform antibody validation using chromogenic and multiplex immunofluorescence approaches to support assay development and target validation. Design, optimize, and validate multiplex immunofluorescence panels using the Lunaphore COMET platform and execute assigned projects with accuracy and timeliness. Collaborate with cross-functional and cross-departmental teams to support target evaluation, assay troubleshooting, and technology implementation. Manage multiple priorities effectively in a fast-paced setting while maintaining scientific rigor and attention to detail. Contribute ideas for workflow improvements, assay optimization, and adoption of novel technologies. Education
Ph.D, M.Sc., B.S in a relevant scientific discipline with significant hands-on experience in histological techniques. Experience
Demonstrated expertise in antibody validation using chromogenic and multiplex immunofluorescence staining methods. Familiarity with automated staining platforms, preferably the Leica BOND system. Strong experience in high-plex spatial biology and multiplex immunofluorescence methodologies, including platforms such as Lunaphore COMET, CODEX, CellScape, and imaging mass cytometry. Experience operating microscopy systems and modern slide scanners such as Leica GT450, Akoya PhenoImager, or Zeiss Axioscan. Proficiency with image visualization and analysis software, such as HALO, QuPath, and ImageJ. Strong scientific judgment, critical thinking, and problem-solving skills. Excellent communication and collaboration skills, with the ability to work effectively across teams. Curiosity, adaptability, and a proactive mindset toward learning and implementing new technologies. Additional Information
Preferred Qualifications: * Experience with assay development, optimization, and troubleshooting in a research or translational setting. Familiarity with tissue biomarker evaluation, spatial tissue profiling, or pathology-adjacent workflows. Experience documenting and standardizing workflows, SOPs, and QC procedures. Ability to independently prioritize requests and manage multiple concurrent projects. Demonstrated experience working in a matrixed, interdisciplinary environment. Exposure to data interpretation and presentation of histology or imaging-based results to scientific stakeholders.
That is an incredibly detailed and exciting job description! This Associate Scientist role is a fantastic blend of hands-on histology, high-plex spatial biology, and cross-functional teamwork.
Before we dive into the mock questions and technical strategies, I want to make sure I tailor this practice specifically to your upcoming panel. Who will you be speaking with in this second-round interview (e.g., the Hiring Manager, a Senior Scientist, or a larger Cross-functional Team), and what specific areas would you most like to focus on practicing today (e.g., technical deep-dives into assay design, behavioral STAR scenarios, or presenting data)?
It's a panel with Senior Scientists; I'd like to focus on technical deep-dives into antibody validation and Lunaphore COMET.
It's wonderful to meet you! Preparing for a second-round panel with Senior Scientists is all about demonstrating your deep, practical understanding of assay design, validation protocols, and the critical thinking required when things don't go perfectly.
Let's kick things off with the first bullet point in our technical prep: the fundamental difference between strategies and multiplex immunofluorescence (mIF) validation strategies.
When you're validating a brand-new primary antibody for single-plex chromogenic IHC, your goal is straightforward: prove that the antibody binds specifically to your target of interest and nothing else.
However, when we shift to multiplex immunofluorescence (mIF), the complexity scales dramatically. You aren't just validating the antibody's specificity to the tissue; you also have to validate its performance within a complex cocktail of other antibodies, fluorescent dyes, and iterative cycle chemistries.
| Validation Parameter | Chromogenic IHC | Multiplex IF (mIF) |
|---|---|---|
| Primary Goal | Single-target specificity & localization | Multi-target co-localization & dynamic range |
| Detection Method | Enzymatic deposition (e.g., DAB brown) | Fluorophores (spectral or sequential elution) |
| Key Cross-Reactivity Concern | Non-specific tissue binding (background) | Antibody-to-antibody steric hindrance & fluorophore bleed-through |
| Control Requirements | Pos/Neg tissue, isotype control | Pos/Neg tissue, isotype, single-stain, & no-primary controls |
To show the Senior Scientists that you have Associate Scientist-level rigor, you'll want to outline a comprehensive validation workflow. This includes running orthogonal validation (like comparing IHC results with western blot or qPCR data), tissue control panels (using positive and negative expressing tissues), and strict isotype or no-primary controls to rule out non-specific binding of your secondary detection reagents.
Would you like us to walk through a concrete, step-by-step example of how you would design a validation protocol for a tricky new antibody, or should we jump straight into how sequential immunofluorescence works on the Lunaphore COMET?
Continue to the Lunaphore COMET sequential immunofluorescence (seqIF) workflow
Let's dive straight into the engine room of high-plex spatial biology: the sequential immunofluorescence (seqIF) workflow on the platform.
The Core Cyclic Workflow
The COMET executes a fully automated, cyclical process to image dozens of different proteins on a single formalin-fixed paraffin-embedded (FFPE) tissue slice. Instead of staining all targets at once, it breaks the process down into repeating rounds, typically processing up to 40 targets on a single slide.
Each cycle consists of three fundamental, microfluidics-driven phases:
The three sequential phases of the Lunaphore COMET sequential immunofluorescence workflow: cyclic staining, fluorescent imaging, and gentle elution.
Let's break down exactly what happens during each phase of this cyclic workflow:
-
Cyclic Microfluidic Staining: The automated fluidic chip seals over the tissue slide. It injects a cocktail of fluorescently labeled primary antibodies (typically 2 to 4 targets per cycle). Because of the active microfluidic flow, incubation takes mere minutes compared to standard overnight staining.
-
Fluorescent Imaging: The platform captures high-resolution, multi-channel fluorescent images of the active cycle's targets, recording their precise spatial coordinates within the tissue architecture.
-
Fluorophore Elution/Quenching: To clear the signal for the next cycle, the system performs a gentle elution step. It uses a specialized buffer to disrupt the antibody-antigen bond or quench the fluorescent signal, preparing the tissue to receive the next round of antibodies without leaving any residual signal or "ghost" images behind. This cycle then repeats until the entire panel is complete.